
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $836.1M | -- | -- | $0.64 | -- |
08/05/2025 | Q2 | $764.4M | $875.6M | $0.61 | $0.62 | -$0.01 |
05/08/2025 | Q1 | $734.1M | $665.1M | $0.61 | $0.58 | $0.04 |
02/07/2025 | Q4 | $717.1M | $625.3M | $0.61 | $0.58 | $0.03 |
10/30/2024 | Q3 | $707.1M | $788.4M | $0.56 | $0.51 | $0.04 |
08/02/2024 | Q2 | $649.4M | $756.7M | $0.50 | $0.48 | $0.02 |
04/30/2024 | Q1 | $601.9M | $596.8M | $0.27 | $0.36 | -$0.08 |
02/02/2024 | Q4 | $572.4M | $474.7M | $0.62 | $0.43 | $0.18 |
11/03/2023 | Q3 | -- | -- | $0.14 | $0.45 | -$0.31 |
07/28/2023 | Q2 | -- | -- | $0.34 | $0.29 | $0.05 |
04/28/2023 | Q1 | -- | -- | $0.36 | $0.30 | $0.05 |
02/03/2023 | Q4 | -- | -- | $0.20 | $0.31 | -$0.11 |
10/28/2022 | Q3 | -- | -- | $0.42 | $0.48 | -$0.06 |
07/29/2022 | Q2 | -- | -- | $0.72 | $0.72 | -$0.00 |
04/29/2022 | Q1 | -- | -- | $0.62 | $0.59 | $0.02 |
02/03/2022 | Q4 | -- | -- | $0.77 | $0.48 | $0.29 |
10/29/2021 | Q3 | -- | -- | $0.53 | $0.50 | $0.03 |
07/29/2021 | Q2 | -- | -- | $0.55 | $0.48 | $0.07 |
04/30/2021 | Q1 | -- | -- | $0.53 | $0.39 | $0.15 |
02/04/2021 | Q4 | -- | -- | $0.56 | $0.37 | $0.19 |
10/30/2020 | Q3 | -- | -- | $0.29 | $0.23 | $0.05 |
07/30/2020 | Q2 | -- | -- | $0.22 | $0.31 | -$0.09 |
04/29/2020 | Q1 | -- | -- | $0.38 | $0.36 | $0.02 |
01/29/2020 | Q4 | -- | -- | $0.33 | $0.55 | -$0.22 |
10/30/2019 | Q3 | -- | -- | $0.42 | $0.49 | -$0.08 |
07/26/2019 | Q2 | -- | -- | -- | $0.49 | -- |
04/30/2019 | Q1 | -- | -- | -- | $0.57 | -- |
02/04/2019 | Q4 | -- | -- | -- | $0.51 | -- |
10/31/2018 | Q3 | -- | -- | -- | $0.50 | -- |
07/26/2018 | Q2 | -- | -- | -- | -- | -- |
04/27/2018 | Q1 | -- | -- | -- | -- | -- |
01/31/2018 | Q4 | -- | -- | -- | -- | -- |
10/26/2017 | Q3 | -- | -- | -- | -- | -- |
07/28/2017 | Q2 | -- | -- | -- | -- | -- |
04/28/2017 | Q1 | -- | -- | -- | -- | -- |
01/31/2017 | Q4 | -- | -- | -- | -- | -- |
10/28/2016 | Q3 | -- | -- | -- | -- | -- |
07/29/2016 | Q2 | -- | -- | -- | -- | -- |
05/02/2016 | Q1 | -- | -- | -- | -- | -- |
02/02/2016 | Q4 | -- | -- | -- | -- | -- |
10/30/2015 | Q3 | -- | -- | -- | -- | -- |
Banco Santander Chile reported $875.6M worth of top line sales in its most recent quarter.
Banco Santander Chile announced earnings per share of $0.61 which represents a miss of analyst forecast a $0.62 per share.
Banco Santander Chile reported -- that represents -- per share over the last quarter.
Banco Santander Chile's earnings are forecast to grow from $1.93 per share to $1.87 per share next year representing an increase of 31.61%.
Banco Santander Chile's next earnings date is August 5, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.